April 22, 2014 | Israeli company Brainsway, which develops non-invasive treatments using transcranial magnetic stimulation (TMS), has reported positive results in a small trial for the treatment of Parkinson’s Disease. The trial was done at the San Raffaelle medical center in Milan, italy, and included 60 patients, which is not a large-enough test group for conclusive results.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments